weight loss with glp-1 agonists Medications: Everything You Need to Know GLP-1 receptor agonists | How
Description
Drucker, D
Currently, no pharmacotherapies are available for the treatment of NAFLD/NASH and the disease is managed by targeting lifestyle changes and treating cardiometabolic risk factors [61]
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Further clinical evidence is needed to verify the effects of GLP-1R agonists on cognitive function and pathology in AD patients
Alcohol, liver disease and the gut microbiota
